ZA863934B - Spiro-imidazolidines as aldose reductase inhibitors - Google Patents

Spiro-imidazolidines as aldose reductase inhibitors

Info

Publication number
ZA863934B
ZA863934B ZA863934A ZA863934A ZA863934B ZA 863934 B ZA863934 B ZA 863934B ZA 863934 A ZA863934 A ZA 863934A ZA 863934 A ZA863934 A ZA 863934A ZA 863934 B ZA863934 B ZA 863934B
Authority
ZA
South Africa
Prior art keywords
imidazolidines
spiro
reductase inhibitors
aldose reductase
neuritic
Prior art date
Application number
ZA863934A
Other languages
English (en)
Inventor
Christopher Andrew Lipinski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA863934B publication Critical patent/ZA863934B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ZA863934A 1985-05-29 1986-05-27 Spiro-imidazolidines as aldose reductase inhibitors ZA863934B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/738,924 US4575507A (en) 1985-05-29 1985-05-29 Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use

Publications (1)

Publication Number Publication Date
ZA863934B true ZA863934B (en) 1988-01-27

Family

ID=24970055

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA863934A ZA863934B (en) 1985-05-29 1986-05-27 Spiro-imidazolidines as aldose reductase inhibitors

Country Status (21)

Country Link
US (1) US4575507A (hu)
EP (1) EP0203791B1 (hu)
JP (1) JPS61277671A (hu)
KR (1) KR890001548B1 (hu)
AT (1) ATE46332T1 (hu)
AU (1) AU560429B2 (hu)
DD (5) DD264214A5 (hu)
DE (1) DE3665584D1 (hu)
DK (1) DK248886A (hu)
EG (1) EG17859A (hu)
ES (2) ES8800228A1 (hu)
FI (1) FI862251A (hu)
GR (1) GR861388B (hu)
HU (4) HU196060B (hu)
IL (1) IL78954A (hu)
NO (1) NO862123L (hu)
NZ (1) NZ216334A (hu)
PH (1) PH22213A (hu)
PL (5) PL147400B1 (hu)
PT (1) PT82650B (hu)
ZA (1) ZA863934B (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU198212B (en) * 1984-07-20 1989-08-28 Pfizer Process for production of spiro-imidasolones
US4762839A (en) * 1985-06-06 1988-08-09 Tanabe Seiyaku Co., Ltd. Quinazolinone copmpounds useful for the prophyloxis and treatment of diabetic complications
JPS63132889A (ja) * 1986-11-21 1988-06-04 Tanabe Seiyaku Co Ltd キナゾリノン誘導体
EP0306525A4 (en) * 1987-03-20 1991-04-24 Alcon Laboratories Inc Use of aldose reductase inhibitors to enhance insulin sensitivity in diabetes mellitus
US5004751A (en) * 1987-08-28 1991-04-02 Mochida Pharmaceutical Co., Ltd. Hydantoin derivatives
US5202339A (en) * 1987-08-28 1993-04-13 Mochida Pharmaceutical Co., Ltd. Hydantoin derivatives
WO1990002126A1 (en) * 1988-08-24 1990-03-08 Mochida Pharmaceutical Co., Ltd. Hydantoin derivatives
US5068332A (en) * 1990-10-12 1991-11-26 American Home Products Corporation Alkylidene analogs of 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones useful as aldose reductase inhibitors
US8326636B2 (en) * 2008-01-16 2012-12-04 Canyon Ip Holdings Llc Using a physical phenomenon detector to control operation of a speech recognition engine
CN104080775A (zh) * 2012-02-09 2014-10-01 勃林格殷格翰国际有限公司 立体选择性合成1,4-保护的9-羟基-5-氧代-1,4-二氮杂-螺[5.5]十一烷的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents
US4117230A (en) 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
ATE23046T1 (de) * 1982-11-10 1986-11-15 Pfizer Sorbinil durch optische aufspaltung mit aminopinanderivaten.
ZA839023B (en) * 1982-12-06 1985-07-31 Pfizer Spiro-3-hetero-azolones for treatment of diabetic complications
US4556670A (en) 1982-12-06 1985-12-03 Pfizer Inc. Spiro-3-hetero-azolones for treatment of diabetic complications
DE3561198D1 (en) * 1984-03-23 1988-01-28 Pfizer Spiro-indenes and spiro-1,2-dihydro-naphthalenes for treatment of diabetic complications
US4762838A (en) 1985-08-30 1988-08-09 Pfizer Inc. Quinazolin-4(3H)-one derivatives as anticoccidial agents

Also Published As

Publication number Publication date
AU5801286A (en) 1987-01-08
HUT49879A (en) 1989-11-28
PL146020B1 (en) 1988-12-31
DD264214A5 (de) 1989-01-25
PT82650B (pt) 1988-11-30
GR861388B (en) 1986-09-17
EP0203791A1 (en) 1986-12-03
PL266364A1 (en) 1988-03-03
FI862251A (fi) 1986-11-30
PL266363A1 (en) 1988-03-03
PL147398B1 (en) 1989-05-31
HU893127D0 (en) 1990-01-28
DK248886A (da) 1986-11-30
DD264215A5 (de) 1989-01-25
ES557391A0 (es) 1988-02-16
IL78954A (en) 1989-09-28
IL78954A0 (en) 1986-09-30
ATE46332T1 (de) 1989-09-15
DE3665584D1 (de) 1989-10-19
ES8801830A1 (es) 1988-02-16
DD251972A5 (de) 1987-12-02
ES8800228A1 (es) 1987-11-01
PL266365A1 (en) 1988-03-03
HU199845B (en) 1990-03-28
FI862251A0 (fi) 1986-05-28
HUT44767A (en) 1988-04-28
PL266366A1 (en) 1988-03-03
DD264213A5 (de) 1989-01-25
DD273258A5 (de) 1989-11-08
KR890001548B1 (en) 1989-05-08
DK248886D0 (da) 1986-05-28
KR860008984A (ko) 1986-12-19
PH22213A (en) 1988-06-28
PL147400B1 (en) 1989-05-31
HU196060B (en) 1988-09-28
HUT49882A (en) 1989-11-28
EP0203791B1 (en) 1989-09-13
NO862123L (no) 1986-12-01
ES555375A0 (es) 1987-11-01
US4575507A (en) 1986-03-11
PT82650A (en) 1986-06-01
EG17859A (en) 1991-11-30
AU560429B2 (en) 1987-04-09
PL147399B1 (en) 1989-05-31
NZ216334A (en) 1988-08-30
PL147397B1 (en) 1989-05-31
JPS61277671A (ja) 1986-12-08

Similar Documents

Publication Publication Date Title
AU589155B2 (en) Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido) azabicycloalkanes
ZA867988B (en) Transdermal treatment for pain and inflammation with 2-amino-3-aroylbenzene-acetic acids,salts and esters
GR861388B (en) Spiro-imidazolidines as aldose reductase inhibitors
IE890177L (en) Piperidinyl derivatives
GR3019893T3 (en) Novel S-adenosyl methionine decarboxylase inhibitors
HUT46043A (en) Process for producing immunstimulant acyltripeptides
DK13484D0 (da) Forbindelser med antihypertensiv virkning
SE8304545L (sv) Bensamidderivat
IT1213579B (it) Flogistica. esteri di salsalato con guaiacolo atti al trattamento di broncopneumapatie a base
GR3004848T3 (hu)
DE3167347D1 (en) New benzothiazine derivatives, processes for preparation thereof and use thereof
HU912567D0 (en) Preparation for decreasing uric acid contain in blood
DE69504392D1 (de) Verwendung von Trovafloxacin oder dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung von H.Pylori Infektionen